Inactive Instrument
Pressure BioSciences, Inc. Stock Other OTC
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 143K 126K 119K 108K 203K 13.76M 204K 1.43M 551K 7.02M 538K 527K 22.57M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.18M 19.09M 17.31M 32.51M 2.2B 32.7M 229M 88.25M 1.12B 86.16M 84.29M 3.61B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8.59K | |
| +0.53% | +3.01% | +46.17% | +34.91% | 251B | |
| +1.27% | +5.32% | +22.99% | -8.03% | 160B | |
| +2.37% | +3.27% | -5.97% | +40.06% | 147B | |
| +0.43% | +0.89% | -55.07% | -17.35% | 63.93B | |
| +0.63% | -1.71% | +13.88% | +24.11% | 50.05B | |
| +1.40% | +8.19% | +42.00% | +56.44% | 49.4B | |
| +1.23% | +4.65% | -14.10% | -18.40% | 48.94B | |
| +2.17% | +4.49% | +51.84% | +60.86% | 43.52B | |
| +0.70% | +13.85% | +196.54% | +105.44% | 41.06B | |
| Average | +0.92% | +4.25% | +33.14% | +30.89% | 94.9B | |
| Weighted average by Cap. | +0.88% | +4.07% | +27.24% | +26.12% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.52M 1.44M 1.3M 2.45M 166M 2.46M 17.22M 6.65M 84.71M 6.49M 6.35M 272M | 1.98M 1.74M 1.64M 1.49M 2.8M 190M 2.82M 19.69M 7.61M 96.88M 7.43M 7.26M 311M |
| Net income | -16.08M -14.14M -13.37M -12.13M -22.78M -1.54B -22.91M -160M -61.83M -787M -60.36M -59.05M -2.53B | -29.31M -25.78M -24.38M -22.11M -41.53M -2.81B -41.77M -292M -113M -1.44B -110M -108M -4.61B |
| Net Debt | 20.53M 18.05M 17.07M 15.48M 29.08M 1.97B 29.25M 204M 78.94M 1.01B 77.06M 75.39M 3.23B | 22.8M 20.06M 18.97M 17.2M 32.31M 2.19B 32.49M 227M 87.7M 1.12B 85.62M 83.76M 3.59B |
Employees
-
